Life Sciences

Finding sustainability in biotechnology, pharmaceutical and medical technology

Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.

Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.

We cover key issues in these areas:




    Connect with us

    Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.

    EY - High quality generics in pharmaceutical market

    High quality generics in pharmaceutical market

    Through ensuring the efficacy of domestically produced generic drugs, the reform aims to increase the quality of care and reduce the financial burden for patients.

    EY - Two-Invoice Policy: A Paradigm Shift in China’s Medical Devices Industry

    Two-Invoice Policy: A Paradigm Shift in China’s Medical Devices Industry

    Following the two-invoice policy roll-out for pharma, one can expect this will pose similar impacts on MedTech stakeholders.